<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04137731</url>
  </required_header>
  <id_info>
    <org_study_id>2019-10138</org_study_id>
    <nct_id>NCT04137731</nct_id>
  </id_info>
  <brief_title>Use of Interferential Current (IFC) Therapy After Total Knee Arthroplasty</brief_title>
  <acronym>IFC</acronym>
  <official_title>The Effect of Short Term Patient Outcomes With the Use of Interferential Current Therapy After Total Knee Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ortho IFC LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Interferential Current Therapy (IFC) is a form of electrical therapy that utilizes two
      simultaneous low frequency electrical stimulation which when they cross interfere with one
      another resulting in an interference or beat frequency. This beat frequency provides a
      therapeutic area of relief by blocking painful stimuli at the area of interest. IFC is
      different from the other electrical treatment modalities used because the cancellation effect
      allows for establishment of the treatment area to be in the deeper tissues of the body,
      whereas other electrical modalities can only be used to treat superficial body parts that lie
      just under the skin.

      The main objective of this proposed study is to assess the post-operative short term outcomes
      of the patients who receive IFC treatment during their post-total knee arthroplasty (TKA)
      surgery hospital stay. The implications of the study would be improved patient outcome which
      could result in shorter hospital stay, reduced use of opioid medication, decreased need for
      manipulation under anesthesia and reduced re-admission rate.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 5, 2019</start_date>
  <completion_date type="Anticipated">March 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction in post-operative pain medication usage</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>Opioid use during the hospital stay after TKA</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in post-operative pain medication usage</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Opioid use during the hospital stay after TKA</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Knee Range of Motion</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>The movement of knee joint, 0: fully straight - 135 : fully bent</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Activity Measure for Post Acute Care (AM-PAC) &quot;6-Clicks&quot; Basic Mobility Inpatient Short Form-Scores</measure>
    <time_frame>48 hours after surgery</time_frame>
    <description>Patient Reported Outcome Tool used by physical therapist to asses patient`s function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Pain Score (VAS)</measure>
    <time_frame>24 Hours after surgery</time_frame>
    <description>VAS asks a patient to mark a place on a scale that aligns with their level of pain smiley face =No pain - sad face =worst pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Pain Score</measure>
    <time_frame>48 Hours after surgery</time_frame>
    <description>VAS asks a patient to mark a place on a scale that aligns with their level of pain smiley face =No pain - sad face =worst pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Osteo Arthritis Knee</condition>
  <arm_group>
    <arm_group_label>IFC Treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The IFC treatment will be used for 30 minutes, twice a day for two days after the total knee arthroplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>One set of device is programmed to be used as Placebo, the subject will feel the vibration but will not receive a therapeutic signal.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Interferential Current Therapy</intervention_name>
    <description>IFC treatment after Total Knee Arthroplasty</description>
    <arm_group_label>IFC Treatment</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:Adult patients with knee osteoarthritis who have failed conservative
        therapy and undergoing elected TKA.

        -

        Exclusion Criteria:

        i. &lt;18 years old ii. Any patient with pacemaker or any electrical stimulator device iii.
        Patients without capacity to consent for the study iv. Patients not able to have local
        nerve block or spinal anesthesia v. Patients with prior chronic opioid use vi. Patients who
        are categorized to have `Severe` fear and anxiety responses to pain, according to the Pain
        catastrophizing scale (PCS) survey.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zeynep Seref-Ferlengez, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sun Jin Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montefiore Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sun Jin Kim, MD</last_name>
    <phone>(718) 920-2060</phone>
    <email>SUKIM@montefiore.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zeynep Seref-Ferlengez, PhD</last_name>
    <phone>(929) 246-6352</phone>
    <email>sereffer@montefiore.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10461</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Senior Operations Manager</last_name>
      <phone>347-577-4441</phone>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 22, 2019</study_first_submitted>
  <study_first_submitted_qc>October 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2019</study_first_posted>
  <last_update_submitted>June 3, 2020</last_update_submitted>
  <last_update_submitted_qc>June 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Sun Jin Kim</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

